Stephen Uden
Net worth: 1 M $ as of 30/05/2026
Net worth: 1 M $ as of 30/05/2026
Stephen Uden is the founder of Rallybio LLC, founded in 2018, holding the titles of President, Chief Executive Officer & Director.
Dr. Uden is the founder of Rallybio Corp., founded in 2018, holding the titles of President, Chief Executive Officer & Director since 2023.
Former jobs include Head-Research & Development at Neurogen Corp.
and Senior Vice President-Research at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
Education includes an undergraduate degree from the University of London.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RALLYBIO CORPORATION 1.73% | 18/12/2025 | 91,920 ( 1.73% ) | 1 M $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 31/12/2017 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Founder | 31/12/2017 |
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30/09/2017 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Chief Tech/Sci/R&D Officer | 13/09/2007 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions